ICCC CIK: 811641

ImmuCell Corporation

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
8.66
FY22:
7.65
FY23:
3.87
FY24:
7.94
FY25:
11.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.26
FY22:
−2.30
FY23:
−5.75
FY24:
−1.64
FY25:
1.65
(positive)
Change from FY21 to FY25
millions USD
FY21:
2.73
FY22:
0.34
FY23:
–
FY24:
1.08
FY25:
4.49
(positive)
Change from FY21 to FY25
millions USD
FY21:
−0.07
FY22:
−2.49
FY23:
−5.77
FY24:
−2.15
FY25:
−1.03
(positive)
Change from FY21 to FY25
millions USD
FY21:
−0.08
FY22:
−2.49
FY23:
−5.77
FY24:
−2.16
FY25:
−1.04

All amounts in millions USD Data sources:SEC EDGARTwelve Data